Tucson, AZ, and College Park, MD, Feb. 7, 2019 – The Association of University Research Parks (AURP), a professional association of university-related research and science parks, announced the appointment of Brian Darmody, Associate Vice President of Corporate Engagement at the University of Maryland (UMD), as its new Chief Executive Officer (CEO). Additionally, the association has opened a new office at the UMD Discovery District in the Washington, DC area, to be known as ‘AURP HQ2.’ Mr. Darmody will immediately assume his new role as CEO at the new location. He will continue his role at UMD and plans to transition out of UMD over time. ...  Read more

Maple Lawn, MD | January 31, 2019 Offit Kurman is pleased to announce the appointment of several new Practice Group Leaders and Practice Group Directors. The changes in leadership and management result from Offit Kurman’s recent expansions and prepare the firm for continued growth in 2019 [Read Here]. ...  Read more

COLUMBIA, MD. (PRWEB) DECEMBER 11, 2018 – Unleashed Technologies, recently named the top Drupal developer in the world by Clutch.co, is rapidly adding team members and will finish 2018 with revenue growth of over 20%. The digital experience agency has hired 13 new team members over the last six months and has also promoted two long-standing team members to new leadership roles within the company.   Read More Here. ...  Read more

Fina Biosolutions LLC announced today it has reached agreement with PATH, a global organization focused on solving some of the world’s most pressing health challenges, under which PATH will provide funding and technical support for the clinical manufacture of FinaBio’s CRM₁₉₇, known commercially as EcoCRM^®. As consideration for this support, FinaBio has licensed PATH its CRM₁₉₇, a key component in conjugate vaccines. Under the license, PATH receives non-exclusive rights to EcoCRM^® for infectious disease vaccines sold to, or for supply to, low-income countries. ...  Read more

Proprietary method of producing CRM₁₉₇ will be used to develop affordable vaccines for children and adults in developing nations ...  Read more

WindMIL Therapeutics, based in Baltimore, Maryland, filed a form D with the U.S. Securities and Exchange Commission, indicating it had raised $32.53 million in equity financing. The Series B round was led by QiMing USA Venture Partners, the new U.S. entity of China company QMing. There was a Series A round worth $11 million. ...  Read more

GAITHERSBURG, MD, June 6, 2018— Sirnaomics, Inc. (www.sirnaomics.com), a leading biopharmaceutical company in development of RNAi therapeutics, announces today that it has closed Series C1 financing of US$25 Million (RMB￥160 Million). This round of financing was led by Yuexiu New Industrial Investment, followed by Sangel Biomedical Venture Capital, HuaKong Equity Investment and Qianhai Shenghui Investment. The proceeds will be used to expand the clinical programs of the lead anti-fibrosis and anti-cancer RNAi therapeutics, strengthen the management team to support growth ...  Read more